Close
What would you like to look for?
Search filters
Patent Litigation Risk for Pharmaceutical Contract Manufacturers (CMO)

Patent Litigation Risk for Pharmaceutical Contract Manufacturers (CMO)

20 April 2023

Pharmaceutical contract manufacturers are exposed to the risk of being sued by patent owners. We explain how they can protect themselves from such lawsuits.

Liberalization of the use of Medical Cannabis in Switzerland

Liberalization of the use of Medical Cannabis in Switzerland

3 August 2022

The liberalization of Swiss narcotics legislation now allows for easier access to and trade in Medical Cannabis. Dan Pruschy and Stefan Kohler give an overview.

How to determine the conversion price in a convertible note?

How to determine the conversion price in a convertible note?

30 November 2021

In the world of startup financing, a convertible note is an instrument offering several advantages for a startup seeking to raise funds in Switzerland.

Integrity and Transparency for Therapeutic Products – 6 Common Myths

Integrity and Transparency for Therapeutic Products – 6 Common Myths

5 June 2020

The new provisions on integrity and transparency in the therapeutic products sector have applied since 1.1.2020. Nevertheless, misinterpretations often occur.

Management of Clinical Trials in COVID-19 Times

Management of Clinical Trials in COVID-19 Times

1 April 2020

The management of clinical trials faces major challenges due to COVID-19.

EU Commission calls for postponement of the MDR start date

EU Commission calls for postponement of the MDR start date

27 March 2020

EU Commission proposes postponement of MDR start date.

MDR Effective from 26 May 2020 – Medical Device Makers Required to Act

MDR Effective from 26 May 2020 – Medical Device Makers Required to Act

6 February 2020

On 26 May 2020, the new EU Medical Device Regulation becomes effective. Swiss medical device manufacturers should adapt to the new rules in good time.

China Adopts Modern Drug Legislation

China Adopts Modern Drug Legislation

31 October 2019

On December 1, 2019, China introduces the drug marketing license holder (MAH) system nationwide. New opportunities for Pharma and Biotech to come.

Trends in the Swiss Cannabis Regulation

Trends in the Swiss Cannabis Regulation

11 April 2019

Current trends in the Swiss cannabis regulation in the context of the marketing of cannabis products and in the life sciences sector.